Cite
Waldeck S, Mitschke J, Wiesemann S, et al. Early assessment of circulating tumor DNA after curative-intent resection predicts tumor recurrence in early-stage and locally advanced non-small-cell lung cancer. Mol Oncol. 2021;doi: 10.1002/1878-0261.13116.
Waldeck, S., Mitschke, J., Wiesemann, S., Rassner, M., Andrieux, G., Deuter, M., Mutter, J., Lüchtenborg, A. M., Kottmann, D., Titze, L., Zeisel, C., Jolic, M., Philipp, U., Lassmann, S., Bronsert, P., Greil, C., Rawluk, J., Becker, H., Isbell, L., Müller, A., Doostkam, S., Passlick, B., Börries, M., Duyster, J., Wehrle, J., Scherer, F., & von Bubnoff, N. (2021). Early assessment of circulating tumor DNA after curative-intent resection predicts tumor recurrence in early-stage and locally advanced non-small-cell lung cancer. Molecular oncology, . https://doi.org/10.1002/1878-0261.13116
Waldeck, Silvia, et al. "Early assessment of circulating tumor DNA after curative-intent resection predicts tumor recurrence in early-stage and locally advanced non-small-cell lung cancer." Molecular oncology vol. (2021). doi: https://doi.org/10.1002/1878-0261.13116
Waldeck S, Mitschke J, Wiesemann S, Rassner M, Andrieux G, Deuter M, Mutter J, Lüchtenborg AM, Kottmann D, Titze L, Zeisel C, Jolic M, Philipp U, Lassmann S, Bronsert P, Greil C, Rawluk J, Becker H, Isbell L, Müller A, Doostkam S, Passlick B, Börries M, Duyster J, Wehrle J, Scherer F, von Bubnoff N. Early assessment of circulating tumor DNA after curative-intent resection predicts tumor recurrence in early-stage and locally advanced non-small-cell lung cancer. Mol Oncol. 2021 Oct 15; doi: 10.1002/1878-0261.13116. Epub 2021 Oct 15. PMID: 34653314.
Copy
Download .nbib